ThomasE.SepeMDFACG, FAASLD, FAGA

Gastroenterology • Providence, RI

Advanced Endoscopic Interventional, Hepatology & Liver Transplantation

University Gastroenterology

Join to view full profile

Dr. Sepe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sepe's full profile

Already have an account?

Office
33 Staniford St
Providence, RI 02905
Phone+1 401-421-8800

Fax+1 401-273-6510

Education & Training

Tufts Medical CenterFellowship, Gastroenterology, 1991 - 1993
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1988 - 1991
Icahn School of Medicine at Mount SinaiClass of 1988

Certifications & Licensure

RI State Medical License 1993 - 2026
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Fellow AASLD, 2007
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Fellow (AGAF) American Gastroenterological Association, 2006
Fellow (FACG) American College of Gastroenterology
Join now to see all

Clinical Trials

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis Start of enrollment: 2015 Jun 01
Completed
Phase 2
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment Start of enrollment: 2015 Sep 22
Terminated
Phase 3
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) Start of enrollment: 2021 Aug 12
Completed
Phase 2
Roles: Contact

Publications & Presentations

PubMed

103 citations
Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.
C Serfaty-Lacrosniere, Richard J. Wood, D Voytko, John R. Saltzman, M C Pedrosa
Journal of the American College of Nutrition. 1995-08-01
21 citations
Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-lab...
Marc Bourlière, Stuart C. Gordon, Eugene R. Schiff, Tram T. Tran, Natarajan Ravendhran
The Lancet. Gastroenterology & Hepatology. 2018-08-01
78 citations
Fixed-Dose Combination Therapy With Daclatasvir, Asunaprevir, and Beclabuvir for Noncirrhotic Patients With HCV Genotype 1 Infection
Fred Poordad, William Sievert, Lindsay Mollison, Michael R Bennett, Edmund Tse
JAMA. 2015-05-05

Press Mentions

Drs. Jeffrey Nadelson, Jonathan Hlivko & More: 4 GI Physicians Making HeadlinesJuly 27th, 2018
Najarian Named Medical Director of University Gastroenterology’s Pathology CenterJune 17th, 2018

Professional Memberships